Possibility of Targeting Claudin-2 in Therapy for Human Endometrioid Endometrial Carcinoma
- 16 June 2020
- journal article
- research article
- Published by Springer Nature in Reproductive Sciences
- Vol. 27 (11) , 2092-2103
Abstract
Claudin-2 (CLDN-2) is a leaky-type tight junction protein, and its overexpression increases tumorigenesis of some types of cancer cells. In the present study, to examine the possibility of targeting CLDN-2 in the therapy for endometrioid endometrial adenocarcinoma, we investigated the regulation and role of CLDN-2 in endometriosis and endometrioid endometrial adenocarcinoma. In endometrioid endometrial adenocarcinoma tissues, marked upregulation of CLDN-2 was observed together with malignancy, while in endometriosis tissues, a change in the localization of CLDN-2 was observed. In cells of the endometrial adenocarcinoma cell line Sawano, which highly express CLDN-2, downregulation of CLDN-2 induced by the siRNA upregulated the epithelial barrier and inhibited cell migration. Furthermore, the downregulation of CLDN-2 affected the cell cycle and inhibited cell proliferation. In Sawano cells cultured with high-glucose medium, CLDN-2 expression was downregulated at the mRNA and protein levels. The high-glucose medium upregulated the epithelial barrier, cell proliferation, and migration, and inhibited cell invasion. The histone deacetylase (HDAC) inhibitor tricostatin A (TSA), which has antitumor effects, downregulated CLDN-2 expression, cell proliferation, invasion, and migration, and upregulated the epithelial barrier. The mitochondrial respiration level, an indicator of cancer metabolism, was downregulated by CLDN-2 knockdown and upregulated by the high-glucose condition. Taken together, these results indicated that overexpression of CLDN-2 closely contributed to the malignancy of endometrioid endometrial adenocarcinoma. Downregulation of CLDN-2 via the changes of the glucose concentration and treatment with HDAC inhibitors may be important in the therapy for endometrial cancer.Keywords
Funding Information
- the Ministry of Education, Culture, Sports, Science, and Technology, and the Ministry of Health, Labour and Welfare of Japan (19K07464, 19K18674)
This publication has 31 references indexed in Scilit:
- Predicted expansion of the claudin multigene familyFEBS Letters, 2011
- Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexesOncogene, 2010
- Biology of claudinsAmerican Journal of Physiology-Renal Physiology, 2008
- Expression of Cdx2 and Claudin-2 in the Multistage Tissue of Gastric CarcinogenesisOncology, 2007
- Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinomaGynecologic Oncology, 2006
- Claudins in occluding junctions of humans and fliesTrends in Cell Biology, 2006
- G1 cell-cycle control and cancerNature, 2004
- Barriers built on claudinsJournal of Cell Science, 2004
- Signalling to and from tight junctionsNature Reviews Molecular Cell Biology, 2003
- MAPK signal pathways in the regulation of cell proliferation in mammalian cellsCell Research, 2002